~" Epidural spinal cord stimulation by means of chronically implanted electrodes was carried out on 121 patients with pain of varied benign organic etiology. In 116 patients, the pain was confined to the back and lower extremities and, of these, 56 exhibited the failed-back syndrome. Most patients were referred by a pain management service because of failure of conventional pain treatment modalities. Electrodes were implanted at varying sites, dictated by the location of pain. A total of 140 epidural implants were used: 76 unipolar, 46 Resume electrodes, 12 bipolar, and six quadripolar. Patients were followed for periods ranging from 6 months to 10 years, with a mean follow-up period of 40 months. Forty-eight patients (40%) were able to control their pain by neurostimulation alone. A further 14 patients (12%), in addition to following a regular stimulation program, needed occasional analgesic supplements to achieve 50% or more relief of the prestimulation pain. Pain secondary to arachnoiditis or perineural fibrosis tbllowing multiple intervertebral disc operations, when predominantly confined to one lower extremity, seemed to respond favorably to this treatment. Uniformly good results were also obtained in lower-extremity pain secondary to multiple sclerosis. Pain due to advanced peripheral vascular disease of the lower limbs was well controlled, and amputation below the knee was delayed for up to 2 years in some patients. Pain due to cauda equina injury, paraplegic pain, phantom-limb pain, pure midline back pain without radiculopathy, or pain due to primary bone or joint disease seemed to respond less well. Patients who responded to preliminary transcutaneous electrical nerve stimulation generally did well with electrode implants. Notable complications included wound infection, electrode displacement or fracturing, and fibrosis at the stimulating tip of the electrode. Three patients in this series died due to unrelated causes. Epidural spinal cord stimulation has proven to be an effective and safe means of controlling pain on a longterm basis in selected groups of patients.
AIN is a complex behavioral process, of which the anatomy and physiology are still poorly understood and are the subject of continuing exploration and research. The therapeutic use of electricity has been applied since ancient times 2~ to cardiac, musculoskeletal, urinary, visual, auditory, and nervous systems ~5 with varying degrees of success.
Neurological applications include stimulation of the peripheral nerve, spinal cord, and deep brain for control of pain, each having a unique history and theoretical basis of action. Shealy, et al., 34 were the first investigators to apply the concept to the spinal cord, Wall and Sweet 4~ and Long ~9 to peripheral nerves, and Adams, et al., ~ to subcortical brain.
The dorsal column stimulator, the first spinal cord system, 14"34' 36 initially showed good results in 90% of cases; however, this fell to 35% at the 2-year follow-up evaluation due to poor patient selection, and thus the entire mode of treatment fell into disrepute. 9"~2'25'2635 Long-term results have improved with the advent of epidural stimulation, improved patient selection,~ s,2o and the recognition of site-specific pain control with varying electrode placement. 27"29"3~ Further refinements have included percutaneous insertion and trial stimulation for several days before internalization of the system. This study summarizes our experience with longterm neurostimulation of the spinal cord for relief of chronic organic pain of nonmalignant origin by means * Success = good or excellent pain relief; initial failure = system not internalized; subsequent failure = initial pain relief but late loss of pain relief.
of epidural stimulating electrodes inserted either percutaneously or through a small laminotomy.
Clinical Material and Methods

Patient Selection
Patients were selected through a well-defined pathway involving evaluation and treatment by medical pain-control personnel in the setting of a pain clinic. In an attempt to quantify the intensity of pain, we use a visual analog scale 6,'~ with values of 0 to 100, and a modified McGill Pain Questionnaire. 23 These were used to evaluate the pain and the patient's reaction to it, and to assign an objective "pain score." The process was repeated at 6 months and at yearly intervals thereafter, and formed one of the yardsticks for evaluation of our results.
Patient selection is a key factor. Our patients fulfilled the following basic criteria: 1) Pain was due to a known benign organic cause. We did, however, accept two cases of spinal cord tumors as both were histologically of low-grade malignancy with anticipated long-term survival. 2) All conventional methods of pain control had failed. 3) Patients had no major abnormal personality traits. Depression, anxiety, and lack of sleep were considered normal responses to chronic pain and did not constitute a contraindication provided they had responded satisfactorily to psychological management. 4) Drug dependency had been gradually eliminated and inappropriate drug use terminated before the electrode was implanted. 5) Most patients had initial satisfactory pain relief with transcutaneous electrical nerve stimulation, but could not continue that type of treatment due to allergic skin reactions, bulkiness of the apparatus, or a reduction in its effectiveness. 6) A trial of percutaneous epidural stimulation had been effective in producing appreciable pain relief. 7) Surgical risks were understood by the patient and informed consent had been obtained.
Technique of Electrode Implantation
The electrodes were implanted either by a percutaneous technique or through a small laminotomy, depending upon the type of electrode to be implanted, as discussed in our earlier report. L4 It is imperative that intraoperative stimulation-induced paresthesias should fully encompass the area of pain to achieve success. The locations of the stimulating tips were usually between the C-6 and T-1 vertebral bodies for upperextremity pain and between T-9 and T-11 for lowerextremity pain.
Clinical Material
In this series, 119 patients with chronic organic pain of varied benign etiology and two patients with cancer pain (spinal cord tumors of low-grade malignancy) were treated by insertion of epidural spinal cord implants. The causes of pain are summarized in Table 1 . These patients were followed for periods from 6 months to 10 years. Seventy-nine patients were male and 42 female, with a mean age of 49 years. One hundred sixteen (96%) presented with pain in the back and lower extremities. Each patient had undergone an average of two previous operations (range none to seven operations); 98 (81%) had had at least one previous operation. In all cases, pain had been refractory to conventional medical management, and activities including employment or daily housework were consequently markedly curtailed.
Electrode Combinations
Including electrodes replaced after initial fracture, a total of 140 epidural implants were used. Of these, 76 (54%) were unipolar Sigma electrodes with a 3-ram stimulating tip; 46 (33%) were Resume electrodes with four large-contact stimulating surfaces, each measuring 12.5 sq mm and needing a laminotomy for placement; 12 (9%) were bipolar; and six (4%) quadripolar with four contact points for stimulation, each 3 mm long and spaced 6 mm apart.* When electrodes had to be replaced because of failure, the Resume electrode was commonly employed (Table 2 ). In no patient was an electrode replaced more than once.
Clinical Evaluation
Each patient entering our program who eventually had an epidural stimulator implanted was followed in a prospective manner with periodic re-examinations *Electrodes manufactured by Medtronic Inc., Minneapolis, Minnesota, and by Neuromed, Fort Lauderdale, Florida. and follow-up telephone interviews for those who could not return to our clinic. The patients in the present study were selected only on the basis of having been followed for at least 6 months from the time of internalization of the system, but also included those without implantation. Our follow-up period ranged from 6 months to 10 years with a mean follow-up period of 40 months.
In evaluating any pain-relieving procedure, it is important to recognize the lack of uniformity of opinion about what constitutes a "good" result. In our earlier report '4 on this subject we used "return to work or previous level of physical activities" as the criterion for identifying a "good" result. However, as our experience increased, we came to realize that pain relief does not parallel ability to return to work. As pointed out by Long, et al., 2~ a middle-aged laborer who has had multiple back operations and suffers from arachnoiditis and who has not worked for over 2 years is unlikely to return to any job for which he is qualified, even with good pain relief.
The criteria for success in this study included: a patient's report of pain relief, both subjective and as judged by the visual analog scale 6'm and modified McGill Pain Questionnaire; 23 reduction in drug intake; increased activity; and actual use of the implant. All patients able to respond to our survey in April, 1989, were categorized into one of four grades: those with an K. Kumar, R. Nath, and G. M. Wyant t Initial failure = system not internalized after trial stimulation; late failure = initially internalized after trial stimulation but late loss of pain relief; successful = good pain relief using stimulator regularly, supplemented with occasional narcotics; excellent = patient using stimulator regularly, no adjunctive narcotics.
electrode that was never internalized (initial failures); those initial successes that later failed (late failures); those who used their implants regularly but required occasional narcotic supplementation (good pain relief); and those who regularly used their electrodes and did not require narcotic medication of any type (excellent pain relief). We have found that more complicated grading systems depend excessively on the patient's subjective impressions of pain quantity, severity, frequency, and character, and therefore lack consistency and reliability; however, it was noted that the use of occasional narcotic analgesics correlated strongly with subjective and objective impressions of good pain relief to levels of about 50% or more of the original pain. All patients were interviewed by a physician not otherwise involved with them, who also reviewed the charts and radiological studies.
Results
Pain Relief
Of the 121 patients included in this study, 27 (22%) did not undergo internalization of the electrode system because of inadequate pain relief during a 1-to 2-week trial stimulation period (initial failures). Of the remaining 94 patients (78%) entered in the study, 75 (62%) in 17 patients revision was followed by satisfactory pain relief; in eight, Sigma electrodes were changed to a Resume system required removal in seven; one case cleared with antibiotics replacement with another electrode successful in all; usually fractured at site of entry into the epidural space replacement successful usually at connection between cord and receiver; replacement successful resolved with bed rest * Three patients in the series died, all from causes unrelated to spinal cord implantation surgery.
FIG. 1. Time course of tolerance development in spinal
cord stimulation patients. The black block indicates patients considered primary failures whose systems were not internalized. Our data suggest that the incidence of tolerance development is maximum in the first 2 years after electrode implantation.
reported excellent pain relief and 19 patients (16%) reported good pain relief during trial stimulation; all 94 had their systems internalized (Table 3) .
After the follow-up period, we found that the pain control of 32 patients with internalized systems (26%) declined to the point where they were not using the equipment (late failures). At the time of writing, 14 patients (11%) had good relief and the number with excellent pain relief had decreased to 48 (40%) from the initial 75 (62%) ( Table 3) . Overall, 62 (51%) of our patients selected for implantation after initial screening were receiving satisfactory pain relief from the electrode that warranted its continued use. If those whose system was not internalized are excluded, our adjusted success rate becomes 66%. It seems, then, that patients fall into two initial categories: those who have an intrinsic receptiveness to this type of electrical pain control (those with internalized systems) and another group whose physiology, anatomy, or pathology does not respond to epidural stimulation (initial failures, those whose systems were not internalized). We believe that further success in this field might be derived by anticipating and preventing a postimplant decline in pain relief; this should be a valuable area for future research.
Patients with the failed-back syndrome secondary to multiple intervertebral disc operations did well in our study (Table 1) , as did patients with lower-extremity pain due to multiple sclerosis. One patient with spinal cord ependymoma did surprisingly well, and continues to have excellent long-term pain relief more than 7 years postimplantation; as a general rule, we do not use epidural stimulators in patients with malignant disease, but the low-grade histology of this tumor and the longterm expected survival prompted our intervention. Pain due to peripheral vascular disease also responded well; it is interesting to note the recent emphasis in the literature describing beneficial effects of epidural stimulation on the peripheral vascular disease itself. 2' 4' 7"821"22"31' 37 Unilateral lower-limb pain responded best in all cases. Patients with disease of the peripheral nerves, facet syndrome, bone and joint disease, cauda equina syndrome, paraplegic pain, and phantom-limb pain did not seem to do as well (Table 1) , although there were few patients in these groups.
Outcome does not appear to be correlated with age, sex, type or number of previous operations, or duration of pain before the implant.
Complications
Complications in our series (Table 4 ) related mostly to hardware problems, especially displacement of the stimulating electrode with a consequent shift in the area of paresthesias and failure of pain control. Movement of the electrode occurred axially as well as laterally, and repositioning of the electrode was usually possible. Although Resume electrodes have a reputation for stability, we encountered several instances of postoperative movement that called for repositioning.
The diagnosis of electrode movement is made by the history of sudden loss of pain control in conjunction with shifted paresthesias, usually after a fall or other trauma. The absence of radiological evidence of electrode shift is not a contraindication to electrode repositioning. Patients with scoliosis or similar spinal deformities were found to have a threefold higher incidence of electrode displacement.
Additional hardware problems included fracture of the electrode wire, usually at the site of entry into the epidural space or at the junction of the electrode with the extension cord of the receiver-stimulator; battery depletion; and electrical leak, usually at the junction of the receiver and extension cord. These accounted for about 80% of all significant complications encountered.
Eight infections occurred in our series, seven of which required removal of the hardware. There were two transient cerebrospinal fluid leaks, each treated by bed rest and not requiring implant removal (Table 4) . Three patients died during the follow-up period, all from causes unrelated to the implant.
Tolerance
Thirty-two of our treatment failures were due to longterm loss of pain relief for reasons unrelated to mechanical problems. These patients all had internalized systems and initially enjoyed good or excellent pain relief with stimulation, but for unknown reasons developed tolerance to stimulation-produced analgesia resulting in gradually declining pain control, sometimes even in the presence of satisfactory coverage of the painful area by paresthesia. This loss tends to occur within the first 4 years after implantation, with the greatest decline during the first 2 years, although sporadic cases may occur throughout the follow-up period. Overall, it seems that systems surviving 4 years have an excellent long-term prognosis for successful pain relief (Fig. 1) . 
Discussion
A review of experience with epidural stimulators at several centers worldwide is presented in Table 5 . It is evident from these results that, overall, long-term relief can be achieved in close to 50% of cases. It must also be noted, however, that some series have a shorter follow-up period and comprise only certain selected pathologies (primarily the failed-back syndrome) that tend to respond well to electrostimulation and give better results ~'s2~ than those from mixed populations~.~.~._~2 .~ that include pathologies with lower yields.
It is a well-recognized phenomenon that epidural neurostimulation in some cases fails without an obvious mechanical cause; '6 this is usually seen as a gradual decrease in the effectiveness of pain relief over several months or years with or without the persistence of paresthesias. Tolerance to the analgesia led to two-thirds of our long-term failures, and has been the subject of much speculation in the literature. We believe that the causes of this late failure, after unrecognized mechanical failure or noncompliance have been eliminated, can be classified as: 1) gross fibrotic changes isolating the stimulating tip of the electrode from the dura and interfering with the spread of current, and 2) plasticity and consequent alteration of ascending afferent nociceptive pathways allowing pain perception after the initially successful interruption of primary pathways.
Reports of fibrosis surrounding electrodes placed over the dura or spinal cord after several months of stimulation have described fibrotic changes, ~3'25'32 in some cases dense enough to cause symptoms of cord compression? 2 It is not known whether the metal of the electrode causes a reaction in susceptible patients or whether the electrical current itself produces excessive fibrosis. Animal and autopsy studies might increase the understanding of this problem; it is certainly not an inevitable consequence of electrode placement in the epidural space." Our own experience in surgical reexploration of such patients has shown that most epidural electrodes that have been in place for a few months have a longitudinal sheath of reactive fibrosis around the tip and stem.
A solution to the problem of anatomical plasticity of pain pathways is conceptually more difficult to grasp. It is clinically apparent that tracts such as the spinoreticular, spinotectal, spinocervical, and secondary afferents of the dorsal columns might all contribute to the production of pain after sectioning or electrical blockade of primary systems? t Finally, patients unresponsive to a trial of epidural stimulation and whose systems therefore were not internalized might be examples of a population whose primary pain pathways are anatomically unsuitable for this treatment, or whose epidural anatomy in some way obviates correct electrode positioning. More sensitive screening methods might be required, perhaps along the lines of somatosensory evoked potential monitoring.
Epidural stimulation has proven to be an effective means of controlling chronic pain in a selected group of patients. It is a safe alternative to narcotics, behavior modification, or destructive operations. Patient selection criteria remain the most important determinants of success.
